The co-transplantation	1
human bone marrow stromal cells and embryo olfactory ensheathing cells	27
bone marrow stromal cells	33
spinal cord injury	125
a rat model YB Deng1	147
Y Liu1	169
WB Zhu1	177
XB Bi1	186
YZ Wang1	194
MH Ye1	204
G-Q Zhou2	215
,3 1Department of Pathophysiology	224
,3 1Department	224
Pathophysiology	242
Zhongshan School of Medicine	259
Zhongshan School	259
Medicine	279
Sun Yat-sen University	289
Guangzhou	313
Guangdong	324
China	335
2Department of Orthopaedics and Traumatology	342
2Department	342
Orthopaedics and Traumatology	357
The University	388
Hong Kong	406
Hong Kong	417
China	428
3Division of Stem Cell and Tissue Engineering	439
3Division of Stem Cell and Tissue	439
3Division	439
Stem Cell and Tissue	452
Engineering	473
State Key Laboratory of Biotherapy	486
State Key Laboratory	486
Biotherapy	510
Sichuan University	522
Chengdu	542
China Background	551
bone marrow stromal cells -LRB- BMSC -RRB-	573
bone marrow stromal cells	573
BMSC	600
olfactory ensheathing cells	610
OEC	639
therapy of spinal cord injury -LRB- SCI -RRB-	699
therapy	699
spinal cord injury -LRB- SCI -RRB-	710
spinal cord injury	710
SCI	730
clinical use	745
the margin neuronal differentiation capacity of BMSC	780
the margin neuronal differentiation capacity	780
BMSC	828
the limited number of isolatable OEC	844
the limited number	844
isolatable OEC	866
This study	882
the efficacy of co-grafting human BMSC and OEC	910
the efficacy	910
co-grafting human BMSC and OEC	926
co-grafting human BMSC	926
OEC	953
thoracic SCI	969
Methods Rat SCI models	984
Methods Rat	984
SCI models	996
cushion forces	1025
OEC	1041
Hoechst 33342 and BMSC	1063
Hoechst 33342	1063
BMSC	1081
BrdU or GFP	1091
BMSC , OEC and BMSC plus OEC	1104
BMSC	1104
OEC	1110
BMSC plus OEC	1118
the injured sites of rat spinal cords	1151
the injured sites	1151
rat spinal cords	1172
Histologic , electrophysiologic and functional approaches	1190
the effects of transplantation of these cell types	1270
the effects	1270
transplantation of these cell types	1285
transplantation	1285
these cell types	1304
Results Behavioral evaluation	1323
an improvement	1360
animals	1378
all cell-based treatments	1391
The co-graft	1418
significantly higher gait scaling	1438
The latency	1473
transcranial magnetic motor-evoked potential -LRB- tcMMEP -RRB- responses	1488
the co-graft group	1580
Larger numbers and sizes	1600
axon bundles	1628
the transitional zone between the normal and injured regions	1649
the transitional zone	1649
the normal and injured regions	1679
the cograft animals in comparison	1727
the cograft animals	1727
comparison	1750
all other animals	1766
bone marrow	1798
stromal cells	1810
neurofilament-positive in the co-grafted animals	1843
neurofilament-positive	1843
the co-grafted animals	1869
the number of glial fibrillary acidic protein-positive cells	1901
the number	1901
glial fibrillary acidic protein-positive cells	1915
the same	1971
all groups	1983
Discussion	1996
our results	2023
the combined use of BMSC and OEC	2048
the combined use	2048
BMSC and OEC	2068
an improved approach	2093
the treatment of SCI	2118
the treatment	2118
SCI	2135
Introduction Severe spinal cord injury -LRB- SCI -RRB-	2141
Introduction Severe spinal cord injury	2141
SCI	2181
axonal pathways extending through the lesion	2237
axonal pathways	2237
the lesion	2271
the loss of neural cells	2295
the loss	2295
neural cells	2307
neurons and glial cells	2331
neurons	2331
glial cells	2343
Great efforts	2356
novel and effective therapeutic strategies	2405
SCI	2452
Transplantation of several cell types , particularly stem cells ,	2457
Transplantation of several cell types	2457
Transplantation	2457
several cell types	2476
particularly stem cells	2496
the most promising strategy	2532
-LSB- 1 5 -RSB-	2560
Grafted stem cells	2567
neuronal or neuroglial cells	2609
endogenous cells destroyed by injury	2657
endogenous cells	2657
injury	2687
regeneration	2707
various mechanisms such as production of neural factors -LSB- 6 10 -RSB-	2728
various mechanisms	2728
production of neural factors -LSB- 6 10 -RSB-	2755
production	2755
neural factors -LSB- 6 10 -RSB-	2769
neural factors	2769
6 10 -RSB-	2785
Bone marrow stromal stem cells -LRB- BMSC -RRB-	2792
Bone marrow stromal stem cells	2792
Bone marrow	2792
stromal stem cells	2804
BMSC	2824
functional recovery	2868
11 13 -RSB-	2889
BMSC	2897
many advantages	2907
cell transplantation therapy for injured brain or spinal cord	2936
cell transplantation therapy	2936
injured brain or spinal cord	2969
injured brain	2969
spinal cord	2986
ex vivo	3031
a large number	3042
addition	3061
at least a portion of transplanted MSC	3071
at least a portion	3071
transplanted MSC	3093
the local injury sites	3141
neurons and glia	3176
rescue damaged neurons from cell death and atrophy	3209
rescue	3209
neurons	3224
cell death and atrophy	3237
an environment permitting axonal regeneration -LSB- 11 15 -RSB-	3272
an environment	3272
axonal regeneration -LSB- 11 15 -RSB-	3298
axonal regeneration	3298
11 15 -RSB-	3319
The survival and neuronal differentiation of transplanted cells	3327
The survival and neuronal differentiation	3327
transplanted cells	3372
the two	3395
factors	3415
the efficacy of functional repair -LSB- 7,11,12,14 16 -RSB-	3427
the efficacy	3427
functional repair -LSB- 7,11,12,14 16 -RSB-	3443
functional repair	3443
7,11,12,14 16	3462
this regard	3481
pre-inducing rapid neural differentiation of BMSC prior to transplantation	3494
pre-inducing rapid neural differentiation	3494
BMSC	3539
transplantation	3553
various chemicals	3576
b-mercaptoethanol , cryptotanshinone and salvia miltiorrhiza	3602
b-mercaptoethanol	3602
cryptotanshinone	3621
salvia miltiorrhiza	3642
17 20 -RSB-	3683
induction	3710
loss of vitality of cells	3737
loss	3737
vitality of cells	3745
vitality	3745
cells	3757
the differentiated neuron-like BMSC	3767
the voltage-gated ion channels	3808
generation of action potentials	3853
generation	3853
action potentials	3867
11 -RSB- and induction protocols	3886
11 -RSB-	3886
induction protocols	3894
further optimization -LSB- 14,21,22 -RSB-	3922
further optimization	3922
14,21,22 -RSB-	3944
The olfactory system	3955
cells	3985
neurogenesis	4015
olfactory receptor neurons -LRB- ORN -RRB- in the periphery	4033
olfactory receptor neurons -LRB- ORN -RRB-	4033
olfactory receptor neurons	4033
ORN	4061
the periphery	4069
life -LSB- 23 -RSB-	4120
life	4120
23 -RSB-	4126
Axons , the nerve processes of these neurons ,	4131
Axons	4131
the nerve processes of these neurons	4138
the nerve processes	4138
these neurons	4161
the olfactory epithelium	4188
the cribriform plate	4221
the glia limitans	4245
they	4270
the central nervous system -LRB- CNS -RRB- environment of the olfactory bulb	4294
the central nervous system -LRB- CNS -RRB- environment	4294
the olfactory bulb	4342
reform synapses	4370
conductivity	4410
The super ability of ORN to regenerate	4424
The super ability	4424
ORN to regenerate	4445
the presence	4478
the glial cells	4494
the olfactory epithelium	4521
olfactory ensheathing cells -LRB- OEC -RRB-	4554
olfactory ensheathing cells	4554
OEC	4583
-LSB- 24 26 -RSB-	4588
Recent studies	4597
OEC	4628
the differentiation of stem cells	4644
the differentiation	4644
stem cells	4667
the olfactory system toward the olfactory neurons -LSB- 27 29 -RSB-	4683
the olfactory system	4683
the olfactory neurons -LSB- 27 29 -RSB-	4711
the olfactory neurons	4711
27 29 -RSB-	4734
progenitor OEC	4753
one of most promising cell sources	4790
one	4790
most promising cell sources	4797
SCI therapy	4829
these studies	4845
OEC	4860
axon regeneration and functional recovery	4891
axon regeneration	4891
the endogenous capacity of host Schwann cells	4958
the endogenous capacity	4958
host Schwann cells	4985
the damaged spinal cord	5014
Schwann cells	5053
OEC	5068
a 3-dimensional matrix	5079
a permissive microenvironment for successful axon regeneration -LSB- 30 -RSB-	5116
a permissive microenvironment	5116
successful axon regeneration -LSB- 30 -RSB-	5150
successful axon regeneration	5150
30 -RSB-	5180
the advantages of BMSC and OEC	5192
the advantages	5192
BMSC and OEC	5210
this study	5224
the efficacy of co-grafting BMSC and OEC	5256
the efficacy	5256
co-grafting BMSC and OEC	5272
the treatment of thoracic SCI	5300
the treatment	5300
thoracic SCI	5317
a rat model	5333
We	5346
co-graft	5366
significant improvement	5391
a single graft of either cell type	5429
a single graft	5429
either cell type	5447
Methods	5472
all experimental procedures	5484
cell harvest	5523
informed consent	5537
the subjects concerned	5570
the subjects	5570
approval	5597
the ethics committee of the institution involved	5622
the ethics committee	5622
the institution involved	5646
the institution	5646
Isolation	5672
human BMSC and cell culture Human BM mononuclear cells	5685
a young healthy donor	5755
ilium BM aspiration	5785
a concentration of 1x107/mL	5824
a concentration	5824
1x107/mL	5843
Gibco	5865
Rockville	5872
MD , USA	5883
10 % fetal bovine serum	5903
FBS ; Boster Ltd , China , Wuhan	5927
FBS	5927
Boster Ltd , China , Wuhan	5932
5 106/cm2	5969
25-cm2 plastic culture flasks	5983
The phenotypes of BMSC of 7-10 passages	6028
The phenotypes	6028
BMSC of 7-10 passages	6046
BMSC	6046
7-10 passages	6054
flow cytometry	6085
fluorescence-labeled antibodies	6106
Ab	6139
CD29-FITC , CD34-FITC , CD44-FITC , CD80-FITC , CD86-PE , CD105-FITC and CD166	6143
FITC -LRB- Pharmingen , Franklin Lakes , NJ , USA -RRB-	6218
FITC	6218
Pharmingen	6224
Franklin Lakes	6236
NJ , USA	6252
certain cases , cultured	6265
certain cases	6265
cells	6289
Ab	6324
Nestin -LRB- Boster -RRB-	6335
Nestin	6335
Boster	6343
neurofilament	6352
NF ; Santa Cruz Biotechnology Inc.	6367
NF	6367
Santa Cruz Biotechnology Inc.	6371
Santa Cruz , CA , USA	6402
Santa Cruz	6402
CA , USA	6414
glial fibrillary acidic protein -LRB- GFAP ; Boster -RRB-	6427
glial fibrillary acidic protein	6427
GFAP ; Boster	6460
GFAP	6460
Boster	6466
BMSC from passages 5-7	6475
BMSC	6475
passages 5-7	6485
passages	6485
5-7	6494
transplantation	6512
Harvest of OEC OEC	6529
Harvest	6529
OEC OEC	6540
the outer -LRB- nerve fiber and glomerular -RRB- layers	6567
nerve fiber and glomerular	6578
nerve fiber	6578
glomerular	6594
aborted or dead fetal olfactory bulbs at 5-7 months of gestation	6616
aborted or dead fetal olfactory bulbs	6616
5-7 months of gestation	6657
5-7 months	6657
gestation	6671
Nash 's methods	6687
Nash 's	6687
modifications -LSB- 31 -RSB-	6707
modifications	6707
31 -RSB-	6722
the nerve fiber and glomerular layers of the olfactory bulb	6736
the nerve fiber	6736
glomerular layers of the olfactory bulb	6756
glomerular layers	6756
the olfactory bulb	6777
any visible meningeal tissue	6819
Tissue pieces	6849
DMEM-F12 medium	6890
30 min	6924
37 °C in 0.125 %	6934
37 °C	6934
0.125 %	6942
trypsin	6949
The remaining trypsin	6958
the addition of 20 % FBS and cells	6999
the addition	6999
20 % FBS and cells	7015
Hanks ' balanced salt solution	7050
Hanks '	7050
centrifugation	7097
1000	7115
r.p.m. , for 10 min	7120
r.p.m.	7120
10 min	7132
The cells	7140
uncoated culture flasks	7167
378C and 5 % CO2 for 18 h. Following overnight incubation	7208
378C	7208
5 % CO2 for 18 h. Following overnight incubation	7217
5 % CO2	7217
18 h. Following overnight incubation	7228
18 h.	7228
overnight incubation	7244
the unattached cells	7266
DMEM-F12 medium	7307
poly-L-lysine-coated culture flasks	7339
OEC of passages 3 or 4	7376
OEC	7376
passages 3 or 4	7383
transplantation	7413
OEC identity	7430
expression of nerve growth factor receptor p75 -LRB- NGFRp75 -RRB-	7460
expression	7460
nerve growth factor receptor p75 -LRB- NGFRp75 -RRB-	7474
nerve growth factor receptor p75	7474
NGFRp75	7508
immunostaining	7523
a specific Ab purchased from Boster	7543
a specific Ab	7543
Boster	7572
Surgical procedures	7580
cell transplantation Female healthy Sprague-Dawley -LRB- SD -RRB- rats	7604
cell transplantation	7604
Female healthy Sprague-Dawley -LRB- SD -RRB- rats	7625
SD	7656
240-270 g in weight	7666
240-270 g	7666
weight	7679
the study	7700
Laminectomy on each rat	7711
Laminectomy	7711
each rat	7726
T9-T10	7752
chloral hydrate anesthesia	7765
The impact rod of the impactor of 10 g	7793
The impact rod	7793
the impactor of 10 g	7811
the impactor	7811
10 g	7827
T10	7851
a height of 50 mm	7872
a height	7872
50 mm	7884
a consistent partial SCI	7900
previously published procedures with a weight-drop device -LSB- 10 -RSB-	7932
previously published procedures	7932
a weight-drop device	7969
Dural	7996
the impact	8032
transplantation	8053
BMSC	8070
incubation	8091
100 µmol BrdU -LRB- Boster -RRB- over 48 h and OEC	8107
100 µmol BrdU -LRB- Boster -RRB-	8107
100 µmol BrdU	8107
Boster	8122
48 h and OEC	8135
48 h	8135
OEC	8144
10 µg/mL	8166
Hoechst 33342 -LRB- Sigma , USA -RRB-	8175
Hoechst 33342	8175
Sigma	8190
USA	8197
10 min	8206
injection	8218
both BMSC and OEC	8229
BMSC	8234
OEC	8243
DMEM-F12 medium	8281
a concentration	8300
50 000 cells/µL	8316
the purpose	8337
direct differentiation of BMSC	8363
direct differentiation	8363
BMSC	8389
neural marker-expressing cells	8399
BMSC at passage 5	8431
BMSC	8431
passage 5	8439
a recombinant adenovirus	8468
green fluorescent protein	8528
eGFP	8555
Ad5/F35eGFP ; Benyuanzhengyang , China , Beijing	8562
Ad5/F35eGFP	8562
Benyuanzhengyang , China , Beijing	8575
transplantation	8618
A multiplicity of infection -LRB- MOI -RRB- of 100	8635
A multiplicity	8635
infection -LRB- MOI -RRB- of 100	8653
infection -LRB- MOI -RRB-	8653
infection	8653
MOI	8664
100	8672
more than 90 % of BMSC	8689
more than 90 %	8689
BMSC	8706
a fluorescent microscope	8745
Sixty rats	8771
four groups	8809
Each of the 15 animals in group 1	8822
Each	8822
the 15 animals in group 1	8830
the 15 animals	8830
group 1	8848
3.4 µL BMSC	8865
1.6 µL OEC suspension ; in group two , 5 mL BMSC only ;	8881
1.6 µL OEC suspension	8881
group two , 5 mL BMSC only	8907
group two	8907
5 mL BMSC	8918
the group 3	8937
5 µL OEC	8950
group 4	8973
5 µL DMEM-F12 only as a control	8982
5 µL DMEM-F12	8982
a control	9004
Cell injection	9015
30 min post-injury	9051
30 min	9051
The cell suspensions and control	9071
the injured spinal cord	9124
three spots on average	9151
three spots	9151
average	9166
the injured center and 2 mm cranial	9175
the injured center	9175
2 mm cranial	9198
2 mm caudal to the central injured site	9215
2 mm caudal	9215
the central injured site	9230
injection	9266
muscle and skin	9277
Rats	9318
daily subcutaneous injection	9350
cyclosporine A -LRB- 10 mg/kg body weight -RRB- for 2 weeks	9382
cyclosporine A -LRB- 10 mg/kg body weight -RRB-	9382
cyclosporine A	9382
10 mg/kg body weight	9398
2 weeks	9424
Cefazolin 25 mg/kg	9433
Cefazolin	9433
25 mg/kg	9443
3 days	9466
urinary tract infection	9484
Urinary bladders	9509
manually twice a day	9539
recovery of urinary function	9566
recovery	9566
urinary function	9578
additional experiments	9599
eGFP-expressing BMSC	9623
eight SCI rats	9667
the procedures	9688
Behavioral test Hind limb motor function	9728
the openfield BBB scoring system -LSB- 32 -RSB-	9788
the openfield BBB scoring system	9788
32 -RSB-	9822
the range from 0 to 21	9844
the range	9844
0 to 21	9859
Individual rats	9868
an open field	9899
4 min	9930
two observers blind to the treatment	9939
two observers	9939
the treatment	9962
The test	9977
once a week	10002
transplantation up to the fifth week	10020
transplantation	10020
the fifth week	10042
Transcranial magnetic motor-evoked potentials -LRB- tcMMEP -RRB-	10058
Transcranial magnetic motor-evoked potentials	10058
tcMMEP	10105
responses tcMMEP	10113
the Viking IV	10149
potential instrument -LRB- Nicolet , Waltham , MA , USA -RRB-	10170
potential instrument	10170
Nicolet	10192
Waltham	10201
MA , USA	10210
tcMMEP responses	10220
stimulation of awake	10256
stimulation	10256
rats	10310
33,34 -RSB-	10341
rats	10358
a prone position on a wooden board	10378
a prone position	10378
a wooden board	10398
a cloth stockingette tacked to the board	10428
a cloth stockingette	10428
the board	10459
Both hind limbs	10470
the left hind limb	10502
the insertion of needle electrodes	10543
the insertion	10543
needle electrodes	10560
the gastrocnemius muscle	10583
the active electrode	10614
the gastrocnemius muscle belly	10647
the reference electrode placed near the distal tendon	10682
the reference electrode	10682
the distal tendon	10718
The ground electrode	10737
the coil and recording electrodes	10792
The tcMMEP responses	10827
subcortical structures	10876
an electromagnetic coil placed over the cranium	10904
an electromagnetic coil	10904
the cranium	10940
A single magnetic pulse with a stimulus intensity of 60 mV and a gain of 500	10953
A single magnetic pulse	10953
a stimulus intensity of 60 mV and a gain of 500	10982
a stimulus intensity of 60 mV	10982
a stimulus intensity	10982
60 mV	11006
a gain of 500	11016
a gain	11016
500	11026
The onset latency time	11040
All animals	11077
surgical procedure	11111
a week	11139
5 weeks	11152
injury	11166
Tissue harvest and histologic evaluation	11174
Tissue harvest	11174
histologic evaluation	11193
Five weeks	11215
animals	11248
physiologic saline	11299
4 % paraformaldehyde in 0.1 M ice-cold phosphate buffer , pH 7.4	11330
4 % paraformaldehyde	11330
0.1 M ice-cold phosphate buffer , pH 7.4	11353
0.1 M ice-cold phosphate buffer	11353
pH 7.4	11386
The whole spinal cord	11394
perfusion	11434
further	11448
4 % paraformaldehyde	11465
overnight	11485
the T9 T11 portion of spinal cord	11519
the T9 T11 portion	11519
spinal cord	11541
Half of the spinal cords in each group	11554
Half	11554
the spinal cords in each group	11562
the spinal cords	11562
each group	11582
30 % sucrose solution	11613
a cryostat at 10-µm thickness	11670
a cryostat	11670
10-µm thickness	11684
immunofluorescent staining for Nestin/NF/GFAP and BrdU	11704
immunofluorescent staining	11704
Nestin/NF/GFAP and BrdU	11735
The remaining cords	11760
paraffin	11797
hematoxylin and eosin staining	11837
Nissl staining	11869
the Pischinger method	11890
axonal staining	11916
the Palmgren method	11938
axon quantification	11963
20 transverse sections	11984
the center of injured spinal cord	12016
the center	12016
injured spinal cord	12030
rats of all four groups	12055
rats	12055
all four groups	12063
The regenerated/survived axons	12093
four	12140
random and 400x	12145
visual fields per section	12171
visual fields	12171
section	12189
injured posterior funiculus	12204
The implanted OEC	12233
the blue fluorescence located in the nucleolus of OEC	12270
the blue fluorescence	12270
the nucleolus of OEC	12303
the nucleolus	12303
OEC	12320
the frozen section	12332
Double immunofluorescence staining for eGFP or BrdU and Nestin/NF/GFAP	12352
Double immunofluorescence staining	12352
eGFP or BrdU and Nestin/NF/GFAP	12391
10 % FBS in PBS , the sections	12446
10 % FBS	12446
PBS , the sections	12457
PBS	12457
the sections	12462
an anti-BrdU -LRB- Boster -RRB-	12495
anti-GFP Ab	12520
either the polyclonal anti-Nestin -LRB- Boster -RRB-	12546
either the polyclonal anti-Nestin	12546
Boster	12581
anti-NF -LRB- Santa Cruz -RRB-	12590
anti-NF	12590
Santa Cruz	12599
anti-GFAP -LRB- Boster -RRB- Ab	12614
Boster	12625
overnight	12637
4 °C	12650
Sections	12655
FITC-conjugated goat anti-mouse secondary Ab -LRB- Boster -RRB-	12684
FITC-conjugated goat	12684
anti-mouse secondary Ab -LRB- Boster -RRB-	12705
anti-mouse secondary Ab	12705
Boster	12730
Cy3-conjugated goat anti-rabbit secondary Ab -LRB- Sigma -RRB-	12742
Cy3-conjugated goat	12742
anti-rabbit secondary Ab -LRB- Sigma -RRB-	12762
anti-rabbit secondary Ab	12762
Sigma	12788
1 h at room temperature	12799
1 h	12799
room temperature	12806
GFP and Nestin or NF double-positive cells	12839
GFP and Nestin	12839
NF double-positive cells	12857
the anti-BrdU Ab	12883
an anti-GFP Ab -LRB- MBL International Corp , Japan -RRB-	12918
an anti-GFP Ab	12918
MBL International Corp	12934
Japan	12958
the above secondary Ab	12979
The sections	13003
an Olympus BX51 fluorescence microscope	13061
quantification of the differentiation rate of implanted BMSC	13106
quantification	13106
the differentiation rate of implanted BMSC	13124
the differentiation rate	13124
implanted BMSC	13152
five transverse sections	13168
the center of injured spinal cord	13202
the center	13202
injured spinal cord	13216
the co-graft and BMSC-grafted rats	13241
the co-graft	13241
BMSC-grafted rats	13258
injured posterior funiculus	13298
A total of four random 200x	13327
A total	13327
four random 200x	13338
visual fields per section	13365
visual fields	13365
section	13383
Statistical analysis All experimental data	13404
Statistical analysis	13404
All experimental data	13425
mean9standard deviation	13466
ANOVA of factorial designed repeated measurement data -LRB- two-way -RRB-	13491
ANOVA of factorial designed repeated measurement data	13491
ANOVA	13491
factorial designed repeated measurement data	13500
factorial	13500
repeated measurement data	13519
two-way	13546
the four treatment groups across all time-points	13579
the four treatment groups	13579
all time-points	13612
The Student 's ttest	13629
The Student 's	13629
comparison of any two treatment groups	13667
comparison	13667
any two treatment groups	13681
Tables 1 and 2	13721
Tables 1	13721
2	13734
each individual time-point	13740
Results Table 1 .	13769
Results	13769
Table 1	13777
BBB locomotion scores	13786
all experimental groups transplanted with different cell types Table 2	13811
all experimental groups	13811
different cell types	13853
Table 2	13875
The latency -LRB- ms -RRB-	13884
the tcMMEP response	13904
all groups transplanted with different cell types Figure 1	13927
all groups	13927
different cell types	13956
Figure 1	13978
Major phenotypes	13988
the surface of human MSC	14018
the surface	14018
human MSC	14033
Figure 2 .	14045
Figure	14045
2	14052
Morphologic characteristics of	14055
Morphologic characteristics	14055
human OEC	14095
-LRB- A -RRB- Human OEC cultured for 3 days , with a small portion of cells	14106
-LRB- A -RRB- Human OEC	14106
A	14107
3 days	14133
a small portion of cells	14146
a small portion	14146
cells	14165
the plate	14183
-LRB- B -RRB- Cultured OEC at passage 3	14194
-LRB- B -RRB-	14194
OEC	14207
passage 3	14214
mainly irregular shapes	14234
multiple slim short processes	14263
-LRB- C -RRB- Most of passage 3 OEC	14294
-LRB- C -RRB- Most	14294
-LRB- C -RRB-	14294
Most	14298
passage 3 OEC	14306
NGFRp75 -LRB- red -RRB-	14341
NGFRp75	14341
red	14350
A negative control	14360
NGERp75 staining where the primary Ab was replaced with unspecific IgG	14383
NGERp75 staining	14383
the primary Ab	14406
unspecific IgG	14439
Figure 3 .	14456
Figure	14456
3	14463
Pathologic features of SCI tissues around lesion sites .	14466
Pathologic features	14466
SCI tissues	14489
lesion sites	14508
relatively normal areas	14534
-LRB- A -RRB- Fourteen days after DMEM-F12	14573
-LRB- A -RRB-	14573
Fourteen days	14577
DMEM-F12	14597
-LRB- B -RRB- Fourteen days post-BMSC/OEC injection .	14620
-LRB- B -RRB-	14620
Fourteen days post-BMSC/OEC injection	14624
Fourteen days	14624
post-BMSC/OEC injection	14638
-LRB- C -RRB- Five weeks post-BMSC/OEC injection , on a transverse section .	14663
-LRB- C -RRB-	14663
Five weeks post-BMSC/OEC injection , on a transverse section	14667
Five weeks post-BMSC/OEC injection	14667
Five weeks	14667
a transverse section	14706
-LRB- D -RRB- Five weeks post-BMSC/OEC injection , on a sagittal section .	14728
-LRB- D -RRB-	14728
Five weeks post-BMSC/OEC injection , on a sagittal section	14732
Five weeks post-BMSC/OEC injection	14732
Five weeks	14732
a sagittal section	14771
-LRB- E -RRB- Five weeks post-OEC injection .	14791
-LRB- E -RRB-	14791
Five weeks post-OEC injection	14795
Five weeks	14795
post-OEC injection	14806
All sections	14826
Arrows	14872
small cavity formation and tissue defects	14888
Figure 4 .	14932
Figure	14932
4	14939
Amino acetic acid silver staining showing axons at the transitional zone .	14942
Amino acetic acid silver	14942
Amino	14942
acetic acid silver	14948
axons	14984
the transitional zone	14993
A and A	15017
A	15017
A	15023
few axons	15033
the transitional zone	15059
the injury region in sham rats	15092
the injury region	15092
sham rats	15113
B , B ' and C ,	15125
B	15125
B ' and C	15128
B	15128
C	15135
A small quantity of axons at the transitional zone and some sparse axons	15143
A small quantity	15143
axons at the transitional zone and some sparse axons	15163
axons	15163
the transitional zone and some sparse axons	15172
the transitional zone	15172
some sparse axons	15198
the injury region in OEC - -LRB- B and B ? -RRB-	15235
the injury region	15235
OEC	15256
B and B	15262
B	15262
B	15268
and BMSC-grafted rats -LRB- C and C ' -RRB-	15272
BMSC-grafted rats -LRB- C and C ' -RRB-	15276
BMSC-grafted rats	15276
C and C '	15295
C	15295
C '	15301
D and D'	15307
D	15307
D'	15313
OEC and BMC co-graft rats	15320
numerous bundles	15347
axons at the transitional zone stretching toward to the distal end	15367
axons	15367
the transitional zone stretching toward to the distal end	15376
the transitional zone	15376
the distal end	15419
the brim of the glial scar	15449
the brim	15449
the glial scar	15461
A	15477
B '	15481
C ' and D'	15485
C '	15485
D'	15492
the squared areas of A , B , C , and D with treble magnifications	15511
the squared areas	15511
A , B , C , and D with treble magnifications	15532
A , B , C , and D	15532
treble magnifications	15552
-LRB- E -RRB-	15575
Axon counting	15579
all groups within the posterior funiculus at the transversal sections	15596
all groups	15596
the posterior funiculus at the transversal sections	15614
the posterior funiculus	15614
the transversal sections	15641
the center of the injured spinal cord	15674
the center	15674
the injured spinal cord	15688
# P < 0.05 in comparison with other groups ; * P <	15713
# P	15713
0.05	15716
comparison with other groups ; * P	15724
comparison	15724
other groups ; * P	15740
other groups	15740
P	15755
0.05 compared with the sham group	15757
0.05	15757
the sham group	15776
Original magnification for A , B C , D	15792
Original magnification	15792
A , B C , D	15819
B C	15822
100x	15833
Figure 5 .	15840
Figure	15840
5	15847
Detection of	15850
Detection	15850
cells	15871
5 weeks	15877
implantation	15891
the injured spinal cord	15907
-LRB- A and B -RRB-	15932
A	15933
B	15939
The Hoechst 33342 fluorescence-labeled cells	15942
Hoechst 33342	15946
clusters	16009
the injured posterior funiculus	16022
partial posterior horn	16058
the OEC -LRB- A -RRB- and co-graft groups -LRB- B -RRB-	16084
the OEC	16084
A	16093
co-graft groups	16100
B	16117
-LRB- C H -RRB- Double immunofluorescence for BrdU/Nestin -LRB- C , D -RRB-	16121
-LRB- C H -RRB- Double immunofluorescence	16121
C H	16122
BrdU/Nestin -LRB- C , D -RRB-	16157
BrdU/Nestin	16157
BrdU/NF -LRB- E , F -RRB-	16177
BrdU/NF	16177
E , F	16186
E	16186
F	16189
BrdU/GFAP -LRB- G , H -RRB-	16196
BrdU/GFAP	16196
longitudinal sections	16216
the injured spinal cord	16241
BMSC-grafted -LRB- C , E and G -RRB- and co-graft groups -LRB- D , F and H -RRB-	16268
BMSC-grafted	16268
C , E and G	16282
C	16282
E and G	16285
co-graft groups	16298
D , F and H	16315
D	16315
F and H	16318
BrdU immunoreactivity	16328
green and the Nestin , NF and GFAP reactivity red	16362
green	16362
the Nestin , NF and GFAP reactivity red	16372
Original magnification	16412
200x for all sections	16439
200x	16439
all sections	16448
-LRB- I -RRB-	16462
I	16463
cells double-positive for BrdU and Nestin , NF and GFAP	16477
cells	16477
BrdU and Nestin , NF and GFAP	16503
BrdU	16503
Nestin , NF and GFAP	16512
Figure 6 .	16534
Figure	16534
6	16541
Co-expression of GFP and neural markers in transplanted GFP-expressing BMSC .	16544
Co-expression	16544
GFP and neural markers in transplanted GFP-expressing BMSC	16561
GFP and neural markers	16561
transplanted GFP-expressing BMSC	16587
-LRB- A -RRB- High GFP expression in BMSC cultured in vitro .	16621
-LRB- A -RRB- High GFP	16621
A	16622
expression in BMSC cultured in vitro	16634
expression	16634
BMSC cultured in vitro	16648
BMSC	16648
-LRB- B -RRB- Transmission confocal microscopy	16672
-LRB- B -RRB-	16672
Transmission confocal microscopy	16676
some GFP-expressing BMSC	16723
NF	16758
red , upper panel	16762
red	16762
upper panel	16767
GFAP -LRB- red , lower panel -RRB- positive -LRB- yellow -RRB-	16784
GFAP -LRB- red , lower panel -RRB-	16784
GFAP	16784
red , lower panel	16790
red	16790
lower panel	16795
3 weeks	16842
Isolation and culture of BMSC and OEC BMSC	16873
Isolation and culture	16873
BMSC and OEC BMSC	16898
BM	16935
adherence	16941
plastic plates	16954
Primary cultures	16970
90 % confluence	16995
9 12 days	17013
Flow cytometry analysis	17042
BMSC of 7-10 passages	17078
BMSC	17078
7-10 passages	17086
CD29 , CD44 , CD105 and CD166	17127
CD34 , CD80 and CD86	17172
Figure 1	17193
Expression of Nestin , NF	17204
Expression	17204
Nestin , NF	17218
Nestin	17218
NF	17226
GFAP was not detectable in cultured BMSC	17233
GFAP	17233
BMSC	17269
OEC	17279
the primary cells	17284
plastic plates	17314
Figure 2A	17366
7 9 days of culture	17381
7 9 days	17381
culture	17393
some cells	17402
multiple slim short processes -LRB- Figure 2B -RRB-	17430
multiple slim short processes	17430
Figure 2B	17461
Most of the cells of passage 3	17473
Most	17473
the cells of passage 3	17481
the cells	17481
passage 3	17494
NGFRp75 positive -LRB- Figure 2C , D -RRB-	17509
NGFRp75	17509
Figure 2C , D	17527
Figure 2C	17527
D	17538
General condition of experimental rats Zero to three rats in each group	17542
General condition	17542
experimental rats Zero to three rats in each group	17563
experimental rats	17563
three rats in each group	17589
three rats	17589
each group	17603
the experiments	17626
5 weeks	17660
a result	17672
systemic infections	17684
the urinary system or surgical lesions or autophagia of hind legs	17720
the urinary system or surgical lesions	17720
the urinary system	17720
surgical lesions	17742
autophagia of hind legs	17762
autophagia	17762
hind legs	17776
All other animals	17787
5 weeks	17820
Rats	17850
the end of the 5 weeks	17876
the end	17876
the 5 weeks	17887
subsequent statistic	17918
Histologic analyzes	17949
the rats that died unexpectedly before the experiments	17973
the rats	17973
the experiments	18012
the pathologic manifestations	18044
glia cell proliferation , hemorrhage and inflammatory cell penetration	18085
white matter and gray matter	18162
white matter	18162
gray matter	18179
the region of injured spinal cord samples	18209
the region	18209
injured spinal cord samples	18223
the remaining rats	18255
various pathologic manifestations	18275
neuraxial distortion	18320
neuraxial disaggregation	18342
neuronal atrophy	18368
cicatrization	18386
small cavity formation	18404
5 weeks	18442
treatment	18456
Figure 3A E	18467
Figure	18467
3A E	18474
There	18481
individual variations and the cell treatment	18505
individual variations	18505
the cell treatment	18531
the overall pathology of injury within the observation period	18586
the overall pathology	18586
injury within the observation period	18611
injury	18611
the observation period	18625
Axon staining	18649
axons at the transitional zone and the injury region	18675
axons	18675
the transitional zone and the injury region	18684
the transitional zone	18684
the injury region	18710
control group rats -LRB- Figure 4A -RRB-	18748
control group rats	18748
Figure 4A	18768
the OEC -LRB- Figure 4B -RRB- and BMSC -LRB- Figure 4C -RRB- groups	18783
the OEC -LRB- Figure 4B -RRB-	18783
the OEC	18783
Figure 4B	18792
BMSC -LRB- Figure 4C -RRB- groups	18807
BMSC	18807
Figure 4C	18813
groups	18824
regenerated/survived axons	18832
small quantities	18881
the transitional zones and sparse axons	18902
the transitional zones	18902
sparse axons	18929
the region of injury	18953
the region	18953
injury	18967
BMSC	18978
OEC co-grafted rats	18984
there	19005
bundles of axons at the transitional zone stretching toward to the distal end	19016
bundles	19016
axons at the transitional zone stretching toward to the distal end	19027
axons	19027
the transitional zone stretching toward to the distal end	19036
the transitional zone	19036
the distal end	19079
many of them	19098
many	19098
them	19106
the transitional zone near the brim of the glial scar -LRB- Figure 4D -RRB-	19124
the transitional zone	19124
the brim of the glial scar -LRB- Figure 4D -RRB-	19151
the brim	19151
the glial scar -LRB- Figure 4D -RRB-	19163
the glial scar	19163
Figure 4D	19179
The count	19191
regenerated/survived axons covering the center of the injured spinal cord	19204
regenerated/survived axons	19204
the center of the injured spinal cord	19240
the center	19240
the injured spinal cord	19254
the co-graft rats	19306
those of the other groups -LRB- Figure 4E -RRB-	19332
those	19332
the other groups -LRB- Figure 4E -RRB-	19341
the other groups	19341
Figure 4E	19359
Detection of implanted cells The fluorescence-marked cells	19371
Detection	19371
implanted cells The fluorescence-marked cells	19384
implanted cells	19384
The fluorescence-marked cells	19400
the injured posterior funiculus	19456
partial posterior horn	19492
the co-graft and OEC-grafted rats -LRB- Figure 5A , B -RRB-	19518
the co-graft	19518
OEC-grafted rats -LRB- Figure 5A , B -RRB-	19535
OEC-grafted rats	19535
Figure 5A , B	19553
Figure 5A	19553
B	19564
Fluorescent OEC	19568
clusters	19610
Fewer labeled cells	19620
Fewer	19620
cells	19634
the region of the anterior funiculus and anterior horn	19653
the region	19653
the anterior funiculus and anterior horn	19667
the anterior funiculus	19667
anterior horn	19694
BrdU immunoreactivity , reflecting the survival of BMSC ,	19709
BrdU immunoreactivity	19709
the survival of BMSC	19743
the survival	19743
BMSC	19759
BMSC	19777
the same areas	19808
There	19824
35 ± 5 cells	19835
35	19835
5 cells	19838
BrdU immunoreactivity per 200x	19859
BrdU immunoreactivity	19859
200x	19885
visual field	19900
the epicenter and vicinity of the injured spine cord	19916
the epicenter and vicinity	19916
the injured spine cord	19946
Cells double-positive for BrdU and Nestin , NF or GFAP	19970
Cells	19970
BrdU and Nestin , NF or GFAP	19996
BrdU	19996
Nestin , NF or GFAP	20005
Figure 5C-H	20045
average	20062
4-5 Nestin-positive and NF-positive cells	20071
field in the co-grafted group -LRB- Figure 4C , E -RRB-	20117
field	20117
the co-grafted group -LRB- Figure 4C , E -RRB-	20126
the co-grafted group	20126
Figure 4C , E	20148
Figure 4C	20148
E	20159
BrdU	20180
there	20192
a mean of 0-1 cells seen in the BMSC-grafted group	20207
a mean	20207
0-1 cells seen in the BMSC-grafted group	20217
0-1 cells	20217
the BMSC-grafted group	20235
2 cells	20268
some visual fields -LRB- Figure 5D , F -RRB-	20303
some visual fields	20303
Figure 5D , F	20323
Figure 5D	20323
F	20334
There	20338
no significant difference	20348
the cells double-positive for BrdU and GFAP -LRB- 1-2 cells/field -RRB-	20377
the cells double-positive for BrdU and GFAP	20377
the cells	20377
BrdU and GFAP	20407
1-2 cells/field	20422
both groups -LRB- Figure 5G , H -RRB-	20442
both groups	20442
Figure 5G , H	20455
Figure 5G	20455
H	20466
the neuronal differentiation rate of implanted BMSC in the co-grafted group	20483
the neuronal differentiation rate	20483
implanted BMSC in the co-grafted group	20520
implanted BMSC	20520
the co-grafted group	20538
that in the BMSC-alone group	20575
that	20575
the BMSC-alone group	20583
there	20608
no difference	20618
the two groups	20640
their gliocyte differentiation rate -LRB- Figure 5I -RRB-	20665
their gliocyte differentiation rate	20665
Figure 5I	20702
It	20714
transplanted cells	20741
more than 2 weeks	20780
host tissue inflammation	20809
BrdU	20843
transplanted BMSC	20874
endocytosis by host cells	20899
endocytosis	20899
host cells	20914
adjacent host cells -LSB- 35 -RSB-	20929
adjacent host cells	20929
35 -RSB-	20950
this	20974
the case in our study	20983
the case	20983
our study	20995
BMSC	21006
GFP	21034
eight additional rats with SCI	21063
eight additional rats	21063
SCI	21090
Fluorescence microscopy	21095
6-h incubation with the adenovirus vector	21138
6-h incubation	21138
the adenovirus vector	21158
GFP	21191
more than 90 % of BMSC	21196
more than 90 %	21196
BMSC	21213
sufficient green fluorescence -LRB- Figure 6A -RRB-	21226
sufficient green fluorescence	21226
Figure 6A	21257
A substantial number of GFP-expressing cells	21269
A substantial number	21269
GFP-expressing cells	21293
the injured posterior funiculus and partial posterior horn	21335
the injured posterior funiculus	21335
partial posterior horn	21371
3 weeks post-transplantation -LRB- Figure 6B -RRB-	21400
3 weeks post-transplantation	21400
Figure 6B	21430
a small number of cells double-positive for GFP and GFAP or NF	21457
a small number	21457
cells double-positive for GFP and GFAP or NF	21475
cells	21475
GFP and GFAP or NF	21501
immunofluorescent staining	21545
specific Ab -LRB- Figure 6B -RRB-	21578
specific Ab	21578
Figure 6B	21591
BBB locomotion scores	21603
BBB scores at all time-points post-transplantation for the co-grafted , BMSC	21625
BBB scores	21625
all time-points post-transplantation for the co-grafted , BMSC	21639
all time-points post-transplantation	21639
the co-grafted	21680
OEC-grafted and control groups are	21706
OEC-grafted and control groups	21706
Table 1	21750
the control group that received only DMEM-F12 medium	21773
the control group	21773
significant improvement	21827
all groups	21867
cellbased treatments	21888
2 weeks	21916
the co-graft group	21925
significantly better improvement of gait scaling compared with all other groups	21962
significantly better improvement	21962
gait scaling compared with all other groups	21998
gait scaling	21998
all other groups	22025
the BMSC group	22058
higher BBB scores	22091
the OEC group -LRB- Table 1 -RRB-	22114
the OEC group	22114
Table 1	22129
Latency of the tcMMEP response The latency of the tcMMEP response	22139
Latency	22139
the tcMMEP response The latency of the tcMMEP response	22150
the tcMMEP response	22150
The latency of the tcMMEP response	22170
The latency	22170
the tcMMEP response	22185
the conductive time	22223
the neural motorial impulse	22246
the spinal cord from the motor center	22290
the spinal cord	22290
the motor center	22311
the gastrocnemius	22331
rats before surgical operation	22353
rats	22353
surgical operation	22365
double phase wave shapes , or sometimes three phase waves ,	22385
double phase wave shapes	22385
three phase waves	22424
tcMMEP response	22459
The mean latencies of the tcMMEP response measured before transplantation	22476
The mean latencies	22476
the tcMMEP response measured before transplantation	22498
the tcMMEP response	22498
transplantation	22534
5.6 ± 0.8 ms. One	22555
5.6 ±	22555
0.8 ms. One	22559
week	22571
transplantation	22582
tcMMEP responses	22599
most	22635
the rats except three	22643
the rats	22643
three	22659
the co-graft group and the other in the BMSC-grafted group	22687
the co-graft group	22687
the other in the BMSC-grafted group	22710
the other	22710
the BMSC-grafted group	22723
2 weeks	22753
the latencies of the tcMMEP response	22762
the latencies	22762
the tcMMEP response	22779
the normal range	22871
The latencies	22889
week 4	22934
transplantation in all groups	22947
transplantation	22947
all groups	22966
There	22978
a significant difference between the co-graft group	22988
a significant difference	22988
the co-graft group	23021
all other groups from week 2 -LRB- Table 2 -RRB-	23044
all other groups	23044
week 2 -LRB- Table 2 -RRB-	23066
week 2	23066
Table 2	23074
Discussion SCI	23085
a devastating neurologic condition	23118
limited therapeutic opportunities	23158
comprehensive intervention strategies	23197
trial	23273
SCI therapy	23283
a potential therapeutic gene -LSB- 21 -RSB-	23317
a potential therapeutic gene	23317
21 -RSB-	23347
application of neurotrophic factors -LSB- 35 -RSB-	23365
application	23365
neurotrophic factors -LSB- 35 -RSB-	23380
neurotrophic factors	23380
35 -RSB-	23402
The co-graft approach	23407
a previous study where neural stem cells and Schwann cells were applied together	23450
a previous study	23450
neural stem cells and Schwann cells	23473
Schwann cells	23547
the survival and differentiation	23575
transplanted neural stem cells	23611
an injured spinal cord rat model -LSB- 36 -RSB-	23645
an injured spinal cord rat model	23645
36 -RSB-	23679
advantage	23692
the limitations of OEC and BMSC	23714
the limitations	23714
OEC and BMSC	23733
the two major cell types that have been suggested as therapeutic for SCI	23747
the two major cell types	23747
therapeutic for SCI	23800
therapeutic	23800
SCI	23816
this study	23821
the synergistic effects of the two cell sources	23850
the synergistic effects	23850
the two cell sources	23877
co-transplantation in rat SCI models	23904
co-transplantation	23904
rat SCI models	23926
Consistent with several previous studies -LSB- 5,11,12,16,18 -RSB- , this study	23942
Consistent	23942
several previous studies -LSB- 5,11,12,16,18 -RSB- , this study	23958
several previous studies	23958
5,11,12,16,18 -RSB- , this study	23984
5,11,12,16,18 -RSB-	23984
this study	24000
transplantation of either of BMSC or OEC	24033
transplantation	24033
either of BMSC or OEC	24052
either	24052
BMSC or OEC	24062
functional recovery	24099
SCI	24125
the conductibility of the injured spine cord	24141
the conductibility	24141
the injured spine cord	24163
some degree	24189
higher scores in motor function tests in combination	24218
higher scores	24218
motor function tests in combination	24235
motor function tests	24235
combination	24259
a better restored tcMMEP	24276
response pattern	24301
the co-graft of OEC and BMSC	24341
the co-graft	24341
OEC and BMSC	24357
the most effective in comparison with other groups	24391
the most effective	24391
comparison with other groups	24413
comparison	24413
other groups	24429
the two cell types	24457
a synergistic way	24492
the functional recovery of SCI	24524
the functional recovery	24524
SCI	24551
The co-grafted group	24556
more axons in the transitional zone	24586
more axons	24586
the transitional zone	24600
the other groups	24636
it	24663
the increased number of axons	24698
the increased number	24698
axons	24722
the result of improved axon survival or axon regeneration	24731
the result	24731
improved axon survival or axon regeneration	24745
a clinical point of view	24795
a clinical point	24795
view	24815
the co-graft of mixed cell types with complementary properties	24832
the co-graft	24832
mixed cell types with complementary properties	24848
mixed cell types	24848
complementary properties	24870
a novel approach for cell transplantation	24907
a novel approach	24907
cell transplantation	24928
SCI and even other tissue types	24952
SCI	24952
other tissue types	24965
The next questions	24985
the two implanted cell types	25029
functional recovery	25084
It	25105
a small portion of implanted BMSC	25136
a small portion	25136
implanted BMSC	25155
Nestin	25180
a marker for neural stem cells	25188
a marker	25188
neural stem cells	25201
NF , a marker for mature neurons ,	25224
NF	25224
a marker for mature neurons	25228
a marker	25228
mature neurons	25241
5 weeks	25257
transplantation	25271
BMSC	25304
differentiation properties in vivo	25317
differentiation properties	25317
vivo	25347
There	25353
a number	25369
published studies	25381
rodent and non-human primate models	25402
new neurons	25454
implanted BMSC and substitute	25488
endogenous neuronal loss	25522
-LSB- 11,12,14 16,18 -RSB-	25547
our results	25580
the portion of BrdU and Nestin or NF doublepositive cells	25602
the portion	25602
BrdU and Nestin or NF doublepositive cells	25617
OEC	25701
OEC	25717
a positive impact on the survival	25734
a positive impact	25734
the survival	25755
neuronal differentiation	25775
BMSC	25803
that	25818
BMSC in the injured spinal cord	25833
BMSC	25833
the injured spinal cord	25841
a gradual and asynchronous process during the formation of neurons	25873
a gradual and asynchronous process	25873
the formation of neurons	25915
the formation	25915
neurons	25932
this	25941
the situation	25959
adult olfactory epithelium	25976
the basal stem cells , immature ORN and mature ORN	26010
the basal stem cells	26010
immature ORN	26032
mature ORN	26049
the neurogenesis of ORN -LSB-	26076
the neurogenesis	26076
ORN -LSB-	26096
24 26	26101
Boyd et al. -LSB- 37 -RSB-	26109
Boyd et al. -LSB-	26109
37 -RSB-	26122
OEC	26140
the neurogenesis of neural stem cells	26152
the neurogenesis	26152
neural stem cells	26172
direct contact	26193
contrast	26212
the expression of GFAP , a marker of neuroglial cells , in implanted BMSC	26222
the expression	26222
GFAP , a marker of neuroglial cells , in implanted BMSC	26240
GFAP , a marker of neuroglial cells ,	26240
GFAP	26240
a marker of neuroglial cells	26246
a marker	26246
neuroglial cells	26258
implanted BMSC	26279
the co-transplantation of OEC	26323
the co-transplantation	26323
OEC	26349
Such direct interaction between the two cell types in vivo shown in our study	26354
Such direct interaction	26354
the two cell types in vivo shown in our study	26386
the two cell types	26386
our study	26422
a role	26448
the same sites	26487
the assumption	26512
multiple approaches	26578
these so-called ` neuronal marker ' molecules	26602
other cell types	26671
certain circumstances	26694
neurotrophic factors excreted by OEC and/or differentiating BMSC	26725
neurotrophic factors	26725
OEC	26758
BMSC	26785
a supporting role and consequently the same functional outcome	26795
a supporting role	26795
consequently the same functional outcome	26817
There	26888
a possibility	26898
phagocytosed or dead transplanted cells with BrdU and Hoechst 33342	26917
phagocytosed or dead transplanted cells	26917
BrdU and Hoechst 33342	26962
BrdU	26962
Hoechst 33342	26971
immunofluorescence	27002
One study	27022
BrdU labeling and GFP expression of BMSC	27045
BrdU labeling and GFP expression	27045
BMSC	27081
transplantation	27092
BMSC transplanted	27130
the intact adult brain	27151
an inflammatory response	27191
BrdU	27220
host neurons and glia -LSB- 38 -RSB-	27244
host neurons and glia	27244
38 -RSB-	27267
the other hand	27275
studies	27291
GFP-transgenic BMSC transplanted to an injured brain area	27315
GFP-transgenic BMSC	27315
an injured brain area	27351
intact brain -LSB- 39 41 -RSB-	27400
intact brain	27400
39 41 -RSB-	27414
this study	27425
we	27437
transplantation of BrdU BMSC , together with OEC or alone ,	27452
transplantation	27452
BrdU BMSC	27471
OEC	27496
neurologic dysfunction	27523
motor function	27558
We	27574
some BrdU-positive cells	27594
neural makers	27629
at least some of the transplanted BMSC	27660
at least some	27660
the transplanted BMSC	27677
we	27732
experiments	27750
GFPexpressing cells	27775
2 weeks	27828
transplanted cells	27873
38 -RSB-	27920
a number of GFP-expressing cells	27934
a number	27934
GFP-expressing cells	27946
neural markers such as NF and GFAP	27979
neural markers	27979
NF and GFAP	28002
we	28024
these cells	28041
longer time periods	28057
these observations	28078
our results using BrdU cells	28110
our results	28110
BrdU cells	28128
the basis of this evidence	28174
the basis	28174
this evidence	28187
we	28202
the possibility of transfer of labeled BrdU of donor cells to host cells	28220
the possibility	28220
transfer of labeled BrdU of donor cells to host cells	28239
transfer	28239
labeled BrdU of donor cells to host cells	28251
labeled BrdU	28251
donor cells to host cells	28267
donor cells	28267
host cells	28282
there	28310
any at all	28320
any	28320
all	28327
summary	28335
our results	28344
co-transplantation of OEC and BMSC	28373
co-transplantation	28373
OEC and BMSC	28395
the functional recovery of SCI in rats , probably	28439
the functional recovery	28439
SCI	28466
rats	28473
such a way	28491
OEC	28507
the neuronal differentiation of implanted BMSC	28536
the neuronal differentiation	28536
implanted BMSC	28568
This study	28584
a basis	28607
protocols	28640
cell transplantation	28654
SCI	28687
other diseases and tissue types	28700
other diseases	28700
tissue types	28719
Acknowledgements This study	28734
Acknowledgements	28734
This study	28751
the Science and Technology Program	28779
Guangdong Province , China -LRB- 2003A3020106 and 2004A30201002 -RRB-	28817
Guangdong Province	28817
China -LRB- 2003A3020106 and 2004A30201002 -RRB-	28837
China	28837
2003A3020106 and 2004A30201002	28844
2003A3020106	28844
2004A30201002	28861
Declaration of interest	28877
Declaration	28877
interest	28892
The authors	28902
no conflicts of interest	28921
no conflicts	28921
interest	28937
The authors	28947
the content and writing of the paper	28985
the content and writing	28985
the paper	29012
References 1 Verma P , Fawcett J. Spinal cord regeneration .	29024
References	29024
1 Verma P , Fawcett J. Spinal cord regeneration	29035
1 Verma P	29035
Fawcett J. Spinal cord regeneration	29046
Adv Biochem Eng Biotechnol 2005 ; 94:43 66 .	29083
Adv Biochem Eng Biotechnol 2005	29083
94:43 66	29115
2 Amador MJ , Guest JD .	29125
2 Amador MJ	29125
Guest JD	29138
An appraisal of ongoing experimental procedures in human spinal cord injury .	29148
An appraisal	29148
ongoing experimental procedures	29164
human spinal cord injury	29199
J Neurol Phys Ther 2005 ; 29:70 86 .	29225
J Neurol Phys Ther 2005	29225
29:70 86	29249
3 Schwab JM , Brechtel K , Mueller CA et al. .	29259
3 Schwab JM	29259
Brechtel K	29272
Mueller CA et al.	29284
Mueller CA	29284
et al.	29295
Experimental strategies	29302
spinal cord regeneration : an integrative perspective	29337
spinal cord regeneration	29337
an integrative perspective	29363
Prog Neurobiol 2006 ; 78:91 116 .	29391
Prog Neurobiol	29391
2006 ; 78:91 116	29406
2006	29406
78:91 116	29411
4 Fernandez E , Mannino S , Tufo T et al. .	29422
4 Fernandez E	29422
Mannino S	29437
Tufo T et al.	29448
Tufo T	29448
et al.	29455
The adult ` paraplegic ' rat : treatment with cell graftings .	29462
The adult ` paraplegic ' rat	29462
treatment with cell graftings	29490
treatment	29490
cell graftings	29505
Surg Neurol 2006 ; 65:223 37 .	29521
Surg Neurol 2006	29521
65:223 37	29538
5 Ramon-Cueto A , Plant GW , Avila J , Bunge MB .	29549
5 Ramon-Cueto A	29549
Plant GW	29566
Avila J	29576
Bunge MB	29585
Long-distance axonal regeneration in the transected adult rat spinal cord	29595
Long-distance axonal regeneration	29595
the transected adult rat spinal cord	29632
olfactory ensheathing glia transplants	29684
J Neurosci 1998 ; 18:3803 15 .	29724
J Neurosci 1998	29724
18:3803 15	29740
6 Okano H	29752
Okada S	29763
Nakamura M	29772
Toyama Y. Neural stem cells	29784
regeneration of injured spinal cord	29816
regeneration	29816
injured spinal cord	29832
Kidney Int 2005 ; 68:1927 31 .	29853
Kidney Int	29853
2005 ; 68:1927 31	29864
2005	29864
68:1927 31	29869
7 Reier PJ .	29882
7	29882
Reier PJ	29884
Cellular transplantation strategies	29894
spinal cord injury and translational neurobiology	29934
spinal cord injury	29934
translational neurobiology	29957
Neuro Rx 2004 ; 1:424 51 .	29985
Neuro Rx 2004	29985
1:424 51	29999
8 Newman MB , Emerich DF , Borlongan CV et al. .	30009
8 Newman MB	30009
Emerich DF	30022
Borlongan CV et al.	30034
Borlongan CV	30034
et al.	30047
Use	30054
human umbilical cord blood -LRB- HUCB -RRB- cells	30061
the damaged brain	30111
Curr Neurovasc Res 2004 ; 1:269 81 .	30130
Curr Neurovasc Res 2004	30130
1:269 81	30154
9 Romano G. Stem cell transplantation therapy	30164
controversy over ethical issues and clinical relevance	30211
controversy	30211
ethical issues and clinical relevance	30228
ethical issues	30228
clinical relevance	30247
Drug News Perspect 2004 ; 17:637 45 .	30267
Drug News Perspect 2004	30267
17:637 45	30291
10 McDonald JW , Liu XZ , Qu Yet al. .	30302
10 McDonald JW	30302
Liu XZ	30318
Qu Yet al.	30326
Qu Yet	30326
Qu	30326
al.	30333
embryonic stem cells	30350
recovery in injured rat	30406
recovery	30406
injured rat	30418
spinal cord	30430
Nat Med 1999 ; 5:1410 2 .	30443
Nat Med 1999	30443
5:1410 2	30456
11 Hofstetter CP , Schwarz EJ , Hess D et al. .	30466
11 Hofstetter CP	30466
Schwarz EJ	30484
Hess D et al.	30496
Hess D	30496
et al.	30503
Marrow stromal cells	30510
guiding strands	30536
the injured spinal cord	30555
recovery	30591
Proc Natl Acad Sci USA 2002 ; 99:2199 204 .	30601
Proc Natl Acad Sci USA 2002	30601
99:2199 204	30629
12 Ankeny DP , McTigue DM , Jakeman LB .	30642
12 Ankeny DP	30642
McTigue DM , Jakeman LB	30656
McTigue DM	30656
Jakeman LB	30668
Bone marrow transplants	30680
tissue protection	30712
axons	30759
contusive spinal cord injury in rats	30771
contusive spinal cord injury	30771
rats	30803
Exp Neurol 2004 ; 190:17 31 .	30809
Exp Neurol 2004	30809
190:17 31	30825
13 Nandoe RD , Hurtado A , Levi AD et al. .	30836
13 Nandoe RD	30836
Hurtado A	30850
Levi AD et al.	30861
Levi AD	30861
et al.	30869
Bone marrow	30876
stromal cells for repair of the spinal cord : towards clinical application	30888
stromal cells	30888
repair	30906
the spinal cord	30916
clinical application	30941
Cell Transplant 2006 ; 15:563 77 .	30963
Cell Transplant	30963
2006 ; 15:563 77	30979
2006	30979
15:563 77	30984
14 Lu P , Blesch A , Tuszynski MH .	30995
14 Lu P	30995
Blesch A , Tuszynski MH	31004
Blesch A	31004
Tuszynski MH	31014
Induction of bone marrow stromal cells to neurons	31028
Induction	31028
bone marrow stromal cells	31041
neurons	31070
differentiation , transdifferentiation , or artifact	31079
differentiation	31079
transdifferentiation	31096
artifact	31121
J Neurosci Res 2004 ; 77:174 91 .	31131
J Neurosci Res 2004	31131
77:174 91	31151
15 Ohta M , Suzuki Y , Noda T et al. .	31162
15 Ohta M	31162
Suzuki Y	31173
Noda T et al.	31183
Noda T	31183
et al.	31190
Bone marrow stromal cells infused into the cerebrospinal fluid	31197
Bone marrow	31197
stromal cells	31209
the cerebrospinal fluid	31236
functional recovery of the injured rat spinal cord	31268
functional recovery	31268
the injured rat spinal cord	31291
reduced cavity formation	31324
Exp Neurol 2004 ; 187:266 78 .	31350
Exp Neurol 2004	31350
187:266 78	31366
16 Lee J , Kuroda S , Shichinohe H et al. .	31378
16 Lee J	31378
Kuroda S	31388
Shichinohe H et al.	31398
Shichinohe H	31398
et al.	31411
Migration and differentiation	31418
nuclear fluorescence-labeled bone marrow stromal cells	31451
transplantation	31512
cerebral infarct and spinal cord injury in mice	31533
cerebral infarct and spinal cord injury	31533
mice	31576
Neuropathology 2003 ; 23:169 80 .	31582
Neuropathology 2003	31582
23:169 80	31602
17 Prockop DJ .	31613
17	31613
Prockop DJ	31616
Marrow stromal cells as stem cells for nonhematopoietic tissues .	31628
Marrow stromal cells	31628
stem cells	31652
nonhematopoietic tissues	31667
Science 1997 ; 276:71 4 .	31693
Science 1997	31693
276:71 4	31706
18 Deng YB , Liu XG , Liu ZG et al. .	31716
18 Deng YB	31716
Liu XG	31728
Liu ZG et al.	31736
Liu ZG	31736
et al.	31743
Implantation of BM mesenchymal stem cells into injured spinal cord	31750
Implantation	31750
BM mesenchymal stem cells	31766
injured spinal cord	31797
de novo neurogenesis and functional recovery	31825
de novo neurogenesis	31825
functional recovery	31850
evidence from a study in rhesus monkeys	31871
evidence	31871
a study in rhesus monkeys	31885
a study	31885
rhesus monkeys	31896
Cytotherapy 2006 ; 8:210 4 .	31912
Cytotherapy 2006	31912
8:210 4	31929
19 Ortiz-Gonzalez XR , Keene CD , Verfaillie CM , Low WC .	31938
19 Ortiz-Gonzalez XR	31938
Keene CD	31960
Verfaillie CM	31970
Low WC	31985
Neural induction of adult bone marrow and umbilical cord stem cells .	31993
Neural induction	31993
adult bone marrow and umbilical cord stem cells	32013
Curr Neurovasc Res 2004 ; 1:207 13 .	32062
Curr Neurovasc Res 2004	32062
1:207 13	32086
20 Woodbury D , Schwarz EJ , Prockop DJ , Black IB .	32096
20 Woodbury D	32096
Schwarz EJ	32111
Prockop DJ	32123
Black IB	32135
Adult rat and human bone marrow stromal cells	32145
Adult rat	32145
human bone marrow stromal cells	32159
neurons	32210
J Neurosci Res 2000 ; 61:364 70 .	32219
J Neurosci Res 2000	32219
61:364 70	32239
21 Lu P , Jones LL , Tuszynski MH .	32250
21 Lu P	32250
Jones LL , Tuszynski MH	32259
Jones LL	32259
Tuszynski MH	32269
BDNF-expressing marrow stromal cells	32283
extensive axonal growth	32328
sites of spinal cord injury	32355
sites	32355
spinal cord injury	32364
Exp Neurol 2005 ; 191:344 60 .	32384
Exp Neurol 2005	32384
191:344 60	32400
22 Neuhuber B , Gallo G , Howard L et al. .	32412
22 Neuhuber B	32412
Gallo G	32427
Howard L et al.	32436
Howard L	32436
et al.	32445
Reevaluation of in vitro differentiation protocols for bone marrow stromal cells	32452
Reevaluation	32452
in vitro differentiation protocols for bone marrow stromal cells	32468
differentiation protocols	32477
bone marrow	32507
disruption	32534
actin cytoskeleton	32548
rapid morphological changes and mimics	32575
J Neurosci Res 2004 ; 77:192 204 .	32634
J Neurosci Res 2004	32634
77:192 204	32654
